Thrombosis with Thrombocytopenia Syndrome (TTS) is a rare yet serious condition linked to certain COVID-19 vaccines, notably adenovirus vector vaccines like AstraZeneca and Johnson & Johnson's ...

Just a few days after British Pharmaceutical giant AstraZeneca announced withdrawal of its COVID-19 vaccine, a new study has linked it to another rare disorder - Vaccine-Induced Immune ...

How it works Convidencia is a viral vector vaccine using adenovirus five. With a viral vector, there is essentially a viral particle, which is programmed not to replicate. So, what is administered ...

An inhalable version of a single-shot, adenovirus-based viral vector vaccine might provide a new option for COVID-19 vaccination. In October 2021, the World Health Organization set a target for ...

In 2012, researchers at the University of Oxford created ChAdOx1, a virus vector vaccine based on a modified simian adenovirus. The researchers chose a simian adenovirus because “if you use a ...

Inactivated virus, viral vector, bacterial vector, subunit and DNA vaccines encoding several antigens have been developed and shown to be immunogenic. Vaccine trials in animal models that mimic ...

This cassette is then transferred to the adenovirus vector plasmid (pAdeno X, Clontech Laboratories or pAd5F35, The Journal of Gene Medicine Volume 6, Issue 6 , Pages 631 - 641). The adenovirus vector ...

The Gene Vector Core was founded in 1997 as the Adenovirus Vector Production Core. Over the years, we have extended our expertise to other popular viral vector systems. Our core has been one of BCM ...